Cell genomics
made easy
Services
We care for your cells
Stem Genomics provides specific services to assess the genetic integrity of stem cells. We offer a range of new tests that use droplet digital PCR and a panel of specific probes to detect most of the recurrent genetic abnormalities observed in stem cells. This innovation, called iCS-digital (in Culture Supernatant digital) PCR, is rapid, robust, and cost-effective, and can be performed on cell culture supernatants.
The iCS-digital TM PSC test detects more than 90% of recurrent genomic abnormalities in human pluripotent stem cells (hPSCs).
The iCS-digital TM MSC test detects more than 80% of the most frequent genomic abnormalities in human mesenchymal stromal/stem cells (hMSCs).
About
Stem Genomics
Stem Genomics develops a technology invented by Prof John De Vos and Dr Said Assou, researchers at the Institute for Regenerative Medicine & Biotherapy (IRMB), University of Montpellier, and co-founders of the company. Located at the heart of the University Hospital Centre of Montpellier, IRMB houses research groups working on basic stem cell research and on innovative applications for regenerative therapy, with the aim of facilitating the transfer from research to clinical applications. Stem Genomics is located at the IRMB Cyborg business incubator and works in close collaboration with IRMB researchers. Stem Genomics has emerged from a prestigious scientific environment.
Many of you asked for a test that would focus on the most common abnormality in hPSCs. So, we made it!
You can now detect specifically the sub-karyotypic 20q11.21 amplification, which represents >20% of recurrent genomic abnormalities in hPSCs, with a rapid, sensitive and easy-to-use digital PCR kit.
Stem Genomics diversifies its offer by launching the iCS-digital TM PSC kit, allowing you to perform this test, already offered in service for more than 2 years, in your facilities.
The iCS-digital TM PSC kit is a precise, fast and sensitive digital PCR test for the detection of more than 90% of the recurrent genomic abnormalities in hPSCs. The iCS-digital TM PSC kit includes eight multiplexed PCR assays that allow the reliable analysis of the 24 regions with the most frequent Copy Number Variations (CNVs) reported in hPSCs. The kit also includes a validated normal genomic DNA control (XY).
Data processing, statistical analysis, and graphical representation of the results can be performed in an automated and explicit way using the iCS-digital TM software provided online by Stem Genomics to help users with data interpretation.